27.11.2012 Views

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information<br />

AGREEMENTS: Name Products Content of Agreement Date<br />

Chelsea<br />

rights to L-Threo DOPS licensing agreement 5/06<br />

Therapeutics (Droxidopa) outside<br />

International Ltd. Asia<br />

Conforma<br />

Amrubicin HCl<br />

licensing agreement 6/05<br />

Therapeutics (Amrubicin)<br />

Eisai Co. Ltd. development,<br />

manufacturing and<br />

marketing of Gasmotin<br />

in 10 Asian countries<br />

licensing agreement 4/06<br />

PRODUCTS ON MARKET: PHARMACEUTICALS UNIT: Amlodin (used in the treatment of hypertension<br />

and angina), Gasmotin (used to improve digestive tract function), Prorenal<br />

(a peripheral circulation stimulant), and Meropen (a carbapenem antiobiotic<br />

preparation)<br />

Dalton Pharma Services<br />

ANIMAL SCIENCE UNIT: disease prevention and treatment products for<br />

pet, livestock, and marine use<br />

349 Wildcat Road<br />

Toronto M3J 2S3, Canada<br />

Phone: (416) 661-2102; Fax: (416) 661-2108<br />

Toll-free phone: (800) 567-5060 (Canada only)<br />

Web: www.dalton.com<br />

E-mail: chemist@dalton.com<br />

KEY PERSONNEL: Peter Pekos; President<br />

Natalie Lazarowych; Director, R&D<br />

EMPLOYEES: 90 employees<br />

HISTORY: Founded and began biotech R&D in 1986<br />

Changed name from Dalton Chemical Laboratories Inc. (4/05)<br />

FACILITIES: 42,000 sq. ft. headquarters<br />

20,000 sq. ft. R&D facilities<br />

20,000 sq. ft. manufacturing facilities<br />

STOCK-FINANCIAL HISTORY: Privately held<br />

BUSINESS STRATEGY: Maintain a position on the forefront of technology in drug discovery, drug<br />

synthesis and analysis through provision of chemistry expertise to generate<br />

new drugs, optimize the synthesis of potential therapeutic candidates, and<br />

provide chemistry expertise to partners in the biotech and pharma fields<br />

Continue to focus on small molecule chemistry, developing novel routes and<br />

molecules as well as providing focused and directed chemistry for our<br />

partners to enhance their own in-house programs and expertise<br />

AGREEMENTS: Name Products Content of Agreement Date<br />

As a contract<br />

services company,<br />

majority of<br />

agreements are<br />

confidential<br />

RESEARCH & DEVELOPMENT: All research and development under contract of clients<br />

PRODUCTS ON MARKET: Fine chemicals, custom peptides, custom chemical synthesis<br />

cGMP manufacturing of active pharmaceutical ingredients and sterile filling<br />

of clinical trail drug products<br />

Copyright ©2006 AHC Media ® 130

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!